| Cancer Therapeutics Program | Chronic Disease Program |
The Cancer Therapeutics Program is based at The Ottawa Hospital Cancer Centre. Scientists, oncologists, and surgeons are investigating everything from basic cancer cell biology to the development of novel targeted therapeutics, to clinical trials and population-based studies in patients. | The Chronic Disease Program includes scientists and clinicians focused on improving the prevention, diagnosis, and treatment of chronic disease. Major areas of research include hypertension and kidney disease, diabetes and obesity, infectious disease (eg. AIDS), and problems of reproduction and development. |
| |
| Clinical Epidemiology Program | Neuroscience Program |
The Clinical Epidemiology Program is focused on improving health through research involving patients and the health care system. Major research themes include circulatory and respiratory health, emergency medicine and critical care, maternal and fetal health, knowledge translation, quality and safety, and health research methods. | The Neuroscience Program includes scientists, neurologists, and neurosurgeons conducting research to improve our understanding of the brain and aid in disease prevention, diagnosis, and treatment. Major areas of research include multiple sclerosis, Parkinson's disease, spinal cord injury, and stroke. |
| |
| Regenerative Medicine Program | Vision Program |
Researchers in the Regenerative Medicine Program are working to improve our understanding of disease and open the road for regenerative medicine to enter the clinic. The Regenerative Medicine Program includes biologists, geneticists, stem cell scientists, and transplant specialists working from various locations including the new Sprott Centre for Stem Cell Research. | The Vision Program is based at the University of Ottawa Eye Institute at the General Campus of The Ottawa Hospital. Researchers are investigating a wide range of vision health issues, with particular emphasis on diseases such as macular degeneration and glaucoma at the new Centre for Research on Age-Related Blindness. |